ment [7, 8] . Ribosomal protein S3 (rpS3) knockdown demonst rated that rpS3 is involved in nuclear factor-kappaB (NF-κB)-medi ated gene regulations [9, 10] . Also, rpS3 has potential roles in pro cesses such as DNA repair and an apoptosis [11] . PEP-1-rpS3 was reported to protect the CA1 region of the hippocampus against cerebral ischemic damage [12] . Chlorogenic acid (CGA), a phenolic compound derived from herbs, is well-known for having various biological properties. For example, it was shown that CGA, as a natural anti-oxidant, effecti vely prevents iron-induced radical formation and exerts strong antimicrobial activity [13, 14] . Also, several studies revealed that CGA is an effective anti-inflammatory, analgesic and antipyretic agent in in vitro experiments and in vivo animal models [15] [16] [17] . Recen tly, numerous bio-molecules such as peptides and pro teins, having therapeutic abilities, have been developed as new drug can didates. However, their large molecular sizes and poor hy d rophilicities reduce and/or restrict their bioavailabilities or deli ve ry to cells or tissues. Therefore, protein transduction do mains (PTD), including trans-activator of transcription (Tat) (RKKRRQRRR) from human immunodeficiency virus-1 and PEP-1 (KETWWET WWTEWSQPKKKRKV) derived from the nuclear lo calization sequence of simian virus 40, were developed to en hance the delivery of poor bioavailable drugs to cells or ti ssues [18] [19] [20] . In previous studies we reported that PTD fused proteins, such as PEP-1-rpS3, PEP-1-Frataxin and Tat-sensitive to apoptosis gene (Tat-SAG), can rapidly cross the blood-brain barrier (BBB) and provide neuronal protection against cerebral ischemic insults in ischemic animal models [21] [22] [23] . In addition, we demonstrated that several molecules, such as bog blueberry an thocyanins (BBA) and pergolide mesylate, have the potential to enhance the transduction efficiency of PTD-fused proteins into cells and animal ti ssues, thereby leading to improved therapeutic activity [24, 25] . There fore, in this study, we examined whether CGA can enhance the transduction efficiency of PEP-1-rpS3 into astrocytes and brain tissues, and, consequently, can increase the po tential of PEP-1-rpS3 to protect neuronal cells against ischemic insult.
MATERIALS AND METHODS

Materials and cell culture
CGA and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies against histidine and β-actin, and pe roxidase conjugated secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other chemi cals and reagents, unless otherwise stated, were obtained from Sigma-Aldrich (St. Louis, MO, USA). The astrocytes were grown in Dulbecco' s modified Eagle' s medium supplemented with 10% heat-inactivated fetal bovine serum, 20 mM Hepes/NaOH (pH 7.4), 5 mM NaHCO 3 and antibiotics (100 μg/ml streptomycin and 100 U/ml penicillin) and kept at 37 o C under a humidified atmosphere of 95% air and 5% CO 2 .
Transductions of PEP-1 fusion proteins into astrocytes
PEP-1-rpS3 and PEP-1-green fluorescence protein (PEP-1-GFP) were purified as described previously [21] . To assess the con centration or time dependent transduction of PEP-1-rpS3 and PEP-1-GFP, cells were grown to confluence in wells of a 6-well plate, pretreated with or without CGA (100 ng/ml) for 1 h, and then expo sed to various concentrations (0.5~2 μM) of each protein for an addi tional 1 h or exposed to each protein (2 μM) for various times (10~60 min). The cells were then harvested and cell extracts were pre pared for Western blot analysis.
Western blot analysis
Equal quantities of β-actin normalized proteins from cell lysate were resolved by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrotransferred to a nitrocellulose mem brane, which was then blocked with 5% non-fat dry milk in PBS. To detect both PEP-1-rpS3 and PEP-1-GFP, which contain histidine sequence and PEP-1 domain, the membrane was pro bed with a rabbit anti-histidine polyclonal antibody (di lu ted at 1 : 10,000), followed by incubation with horseradish pe roxidase-conjugated goat anti-rabbit secondary antibody (diluted at 1 : 10,000). The membrane was visualized by enhanced che miluminescence according to the manufacturer' s instructions (Amersham, Piscataway, NJ, USA).
Viability assay
An established assay based on MTT was used to assess cell viability [23] . Astrocytes were grown to 70% confluence in wells of a 96-well plate and pretreated with CGA (100 ng/ml) for 1 h. The cells were incubated with various concentrations of PEP-1-rpS3 (0.5~2 μM) for an additional 1 h and cell toxicity was induced by treat ment with H 2 O 2 (1 mM) for 4 h. Cellular viability was ex pressed as a percentage of a H 2 O 2 untreated control.
Animals
Mongolian gerbils (Meriones unguiculatus) were purchased from the Hallym University Experimental Animal Center. They were per mi tted free access to food and water, ad libitum. 
In vivo transduction of PEP-1-rpS3 into brain tissues
To examine the effect of CGA on the transduction of PEP-1-rpS3 into brain tissues, CGA (100 μg/kg) was i.p. administered, followed by an i.p. injection of PEP-1-rpS3 (150 μg/kg) 1 h later. Brain biopsy samples were immunostained using a rabbit anti-histidine (1 : 400) and biotinylated goat anti-rabbit secondary antibodies (1 : 200). The sections were visualized with 3,3'-diaminobenzidine (DAB) in 0.1 M Tris buffer and observed under a microscope (Olympus DP72 digital camera, Tokyo, Japan).
Induction of cerebral forebrain ischemia in experimental model
To determine whether CGA affects the protective effect of PEP-1-rpS3 against ischemic damage, male Mongolian gerbils were randomly divided into 5 groups (n=7); sham-operated, vehicle treated, CGA-treated, PEP-1-rpS3-treated, and PEP-1-rpS3 + CGA treated groups. CGA dissolved in PBS was i.p. injected (100 μg/kg). Then, PEP-1-rpS3 (150 μg/kg) was administered i.p. 30 min prior to the occlusion of common carotid arteries. For the occlusion of common carotid arteries, gerbils were placed under general anesthesia with a mixture of 2.5% isoflurane (Abbott Laboratories, North Chicago, IL, USA) in 33% oxygen and 67% nitrous oxide. A midline ventral incision was made in the neck, and the common carotid arteries were isolated, freed of nerve fibers, and occluded with nontraumatic aneurysm clips. Complete interruption of blood flow was confirmed by observing the central artery in the eyeball using an ophthalmoscope. After 5 min occlusion, the aneurysm clips were removed. The restoration of blood flow (reperfusion) was observed directly under the ophthalmoscope. Sham-operated animals (n=7) were subjected to the same surgical procedures except that the common carotid arteries were not occluded. Rectal temperature was monitored and maintained at 37± 0.5°C before, during, and after the surgery, until the animals had recovered fully from anesthesia. Immediately following ischemia-reperfusion, animals from each group were euthanized for cresyl violet staining.
Tissue processing for histology
All animals from each group were anesthetized with sodium pen tobar bital and transcardially perfused with 4% paraformal dehyde in 0.1 M PBS (pH 7.4). Brain tissues were post-fixed in the same fixative for 4 h, followed by infiltration with 30% sucrose over night. The tissues were then frozen and sectioned with a cryo stat at 50 μm. Cresyl violet staining was performed as des cribed pre viously [22, 23] .
Statistical analysis
Data are expressed as the means±SD. Comparison between groups was performed by Student' s t test. Values of p<0.01 and p<0.05 were considered to be statistically significant.
RESULTS
CGA enhanced the transduction of PEP-1 fused proteins into astrocytes
We previously reported that PEP-1-rpS3 can be effectively transduced into cells and animal tissues, thereby providing protection against UV damage or ischemic insult [12, 21] . To assess the effect of CGA on the transduction efficiency of PEP-1-fused proteins, we compared the extent of transduction of PEP-1-rpS3 and PEP-1-GFP into astrocytes in the presence or absence of CGA using Western blot analysis. The chemical structure of CGA and schematic sequences of PEP-1-rpS3 and PEP-1-GFP were shown in Fig. 1 . As shown in Fig. 2 , both PEP-1-rpS3 and PEP-1-GFP were delivered in a dose-and time-dependent manner to the cells without treatment of CGA. Particularly, when pretreated with CGA, a clear in crease in the transduced amount of PEP-1-rpS3 and PEP-1-GFP was observed, compared to the samples without CGA pre treatment. These results demonstrated that CGA has the ability to improve the in vitro transduction of PEP-1 fused proteins.
CGA produced no cellular toxicity
We next examined whether the enhanced transduction of PEP-1-fu sion proteins is ascribed to altered membrane permea bili ty induced by CGA. As illustrated in Fig. 3 , H 2 O 2 (1 mM) produced apparent cell death to 44% of control cells. Although CGA is known to have anti-oxidant properties, CGA alone at the concentration (100 ng/ ml) which was employed in our experiments failed to recover the cell viability against H 2 O 2 -induced oxidative stress. Cell viability did, however, increase with increasing concentrations of PEP-1- At the maximal concentration of PEP-1-rpS3, CGA pretreatment enhanced cell viability, by approximately 11%. These data suggest that CGA can enhance the anti-oxidant activity of PEP-1-rpS3 without dis playing any additional toxicity or anti-oxidative effects to astro cytes.
In vivo transduction of PEP-1-rpS3 into the brain tissues was enhanced in the presence of CGA
Next to verify whether CGA could increase the in vivo transduc tion of PEP-1-rpS3 as well, CGA was i.p. injected at a dose of 100 μg/kg 1 h prior to injection of PEP-1-rpS3 (150 μg/kg) and the distribution of PEP-1-rpS3 in the brain was identified by immuno histological staining. Fig. 4 shows results consistent with in vitro transduction of PEP-1-rpS3. rpS3 is not found in the brain tissues at all. The significant transduction of PEP-1-rpS3 was found in the CA1 regions of the hippocampus. In addition, much st ron ger signals in the same region were identified after combi natio nal treatment with PEP-1-rpS3 + CGA than the sample treated with PEP-1-rpS3 alone, suggesting the effectiveness of CGA in the transduction of this fusion proteins.
CGA apparently increased the neuroprotective effect of PEP-1-rpS3 against ischemic damage
Transient ischemia induces the neuronal loss in the CA1 region of the hippocampus. We evaluated protection in each group against ischemia induction after the administration of CGA, PEP-1-rpS3, and CGA + PEP-1-rpS3 using cresyl violet staining and histo logical analysis. As shown in Fig. 5 , most of cells in CA1 region in the vehicle-treated group were dead. Treatment with CGA sli ghtly increased the number of viable cells in the CA1 region and also treatment with PEP-1-rpS3 clearly exhibited en han ced protec tion against cell death in the CA1 region. Above all, the extent of neuronal protection in the sample treated with CGA + PEP-1-rpS3 was similar to that in the sham control, demon st ra ting that com binational treatment with CGA + PEP-1-rpS3 was much more protective against neuronal cell death induced by transient ischemia than that of CGA or PEP-1-rpS3 alone.
DISCUSSION
CGA is a polyphenol, which is abundantly found in coffee, fruits and vegetables. Several studies have provided evidence showing that CGA has various biological activities such as anti-oxidant, anti-inflammatory and analgesic. CGA has the ability to suppress 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced tumor promotion in a mouse model [26] and to induce p38 mitogenactivated protein kinase (MAPK)-dependent apoptosis in chronic myelogenous leukemic cells [27] . Also, the mechanism for antitumor activity of CGA suggests that, following treatment with UVB and TPA, CGA up-regulates cellular phase II anti-oxidant enzymes and suppresses activation of nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1) and MAPK signaling pathways mediated by ROS [28] . CGA inhibits synthesis and release of inflammatory mediators, such as TNF-α and NO, and provides anti-inflammatory and analgesic activities in animal models of carrageenin-induced inflammation and formalin-induced pain [16] . Therefore, up-regulating levels of anti-oxidant enzymes in target cells or tissues can be proportional to the enhancement of therapeutic potentials of these enzymes. Increasing the intracellular levels of therapeutic proteins is also proposed as an effective therapy against several ROS-related diseases. Previously, we reported that, through fusion of rpS3 with PEP-1, one PTD, PEP-1-rpS3 can be effectively transduced into cells or brain tissues, suppress ROS generation and ischemic damage induced by oxidative stress, and functions as a neuroprotective agent [12] .
In this study, we investigated a novel function of CGA to enhan ce the delivery of PEP-1 fusion proteins to cells and tissues, thereby in creasing their cellular bioavailability and therapeutic potential. Our cell viability data demonstrated that, although CGA is wellknown as an anti-oxidant molecule, CGA alone, at 100 ng/ml con cen t ration, had no influence on H 2 O 2 -induced toxicity in astro cytes (Fig. 3 ) and exhibited similar cell viability to the sample trea ted with H 2 O 2 . However, the existence of CGA improves the neuroprotective effect of PEP-1-rpS3 against H 2 O 2 , compared to the samples treated with PEP-1-rpS3 alone. Therefore, as we did not observe any clear neuroprotective effect of CGA alone, in this experiment we excluded the possibility that CGA provided any direct neuronal protection against H 2 O 2 in the sample co-treated with CGA+PEP-1-rpS3. Next, to investigate the reason for the enhanced neuroprotective activity in the sample co-treated with CGA and PEP-1-rpS3, we examined whether treatment with CGA could affect transduction of PEP-1-rpS3 into astrocytes and sub sequently enhance its neuroprotective effect against ischemic insult. As shown in Fig. 2 , the transduction data show that treatment with CGA can considerably improve the transduction of PEP-1-rpS3 into astrocytes. Moreover, in vivo transduction data con firmed that PEP-1-rpS3, which has the ability to spontaneously cross the BBB, exhibited enhanced transduction into brain ti ssues in the presence of CGA (Fig. 4) , as evidenced by in vitro transduc tion results. As a result of the enhanced transduction of PEP-1-rpS3 by CGA, an animal transient ischemia model provides the evi dence that, even if CGA alone showed slight neuroprotection in the CA1 region of the hippocampus, CGA has the ability to defi nitely improve the transduction of PEP-1-rpS3 into brain tissues, re sulting in improved neuroprotective effects of PEP-1-rpS3 against ischemic insult (Fig. 5) .
Various biological activities of polyphenol such as CGA have been drawing much attention from many research groups. Because of the characteristic physicochemical properties of polyphenol, they chelate metals, scavenge ROS and exert a broad spectrum of bio logical activities [16, 29] . On the other hand, our present study demon strates that CGA also has the novel function of enhancing the transduction of PEP-1-fusion proteins beyond its already wellknown anti-oxidant function. One reason for the different results may be that the function of CGA as an anti-oxidant in other litera ture was evaluated at the higher concentrations than that we used in this study. Moreover, others have suggested that there is a corre lation between biological activity and the concentration of bio molecules. For instance, although (-)-epigallocatechin-3-gallate (EGCG), one of polyphenols, exhibited effective in vitro anti-cancer activity in the concentration of 10~100 μM, it is possible that its concentration in plasma or tissues was observed as very low by oral administration because of very poor bioavailabilty [29, 30] . Thus, it is considered that the concentration of CGA, cell lines, ex peri mental conditions and assay methods may contribute to absolu tely different results.
Many research groups have tried to explain how PTD could tra verse the cellular membrane and the BBB. Although the mecha nisms of PTD transduction are suggested such as a direct pe ne t ration via electrostatic interaction with negatively charged phos pholipids, endocytosis-mediated pathways, and a formation of inverted micelles or pores structure, these mechanisms are still controversial [31] [32] [33] [34] . Besides CGA, several molecules such as DMSO, BBA, and pergolide mesylate were reported to have the potential to enhance the transduction of PTD fusion pro te ins [24, 25, 30] . Even if, until now, it is still not clear which mo lecular events mediated by CGA or other molecules are res pon sible for enhancing the transduction of PTD fusion proteins, it is presumable that CGA might be related with one of the mecha nism suggested above or increase permeability of the cellular membranes, subsequently facilitating transduction of PTD into cells and BBB. Therefore, additional studies are required to investigate molecules and pathways to take part in the process of transduction of PTD fusion proteins. Also, it is undoubtedly necessary to de velop agents which could enhance transduction efficiency for therapeutic molecules having poor transduction efficiency.
Taken our results together, we demonstrate that CGA has the novel activity to significantly enhance transduction efficiency of PEP-1-fused therapeutic proteins into target cells or tissues, and, con sequently, lead to improvement of their therapeutic potential.
